Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market: 2019-2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 9, 2019--The “Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
T he continuous subcutaneous insulin therapy devices market will register a CAGR of more than 9% by 2023.
The rising partnerships to gain prominence in the market
Vendors are entering into strategic alliances and partnerships for integration of available and emerging technologies into their products. Such partnerships will help the market to grow.
Rise in awareness about diabetes
The rise in prevalence of diabetes has resulted in increasing awareness efforts by various organizations globally. Programs such as the Diabetes Activities Under State Public Health Actions increase the participation of people.
Rise in product recalls
The growth of the market is hindered by product recalls. Product recalls affect the sales of a company negatively, which results in a decline in it market share. Also, they affect the brand image of vendors, thereby reducing profit margins.
Key PlayersCellnovo F. Hoffmann-La Roche Insulet Medtronic Tandem Diabetes Care
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 04: MARKET SIZINGMarket definition Market sizing 2018 Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCTMarket segmentation by product Comparison by product Tethered - Market size and forecast 2018-2023 Patch - Market size and forecast 2018-2023 Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPEGeographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDSTechnological advances Increase in grants for product development Rise in strategic partnerships
PART 11: VENDOR LANDSCAPEOverview Landscape disruption Competitive scenario
PART 12: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors Cellnovo F. Hoffmann-La Roche Insulet Medtronic Tandem Diabetes Care
For more information about this report visit https://www.researchandmarkets.com/research/jb3wgc/global_continuous?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005375/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs,Diabetes Drugs
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/09/2019 06:41 AM/DISC: 01/09/2019 06:41 AM